(Q72789955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Alpha- and gamma-interferon versus alpha-interferon alone in chronic hepatitis B. A randomized controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

V Carreño

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

A Moreno

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

F Galiana

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

F J Bartolomé

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 March 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

321-325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

Therapy of chronic hepatitis B with recombinant human alpha and gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

An assay for the detection of the DNA genome of hepatitis B virus in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

Neutralization of interferon by antibody: appraisals of methods of determining and expressing the neutralization titer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980212-0

7 January 2021

10.1016/S0168-8278(05)80212-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8315260%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference